Primary |
Attention Deficit/hyperactivity Disorder |
67.3% |
Adhd |
15.4% |
Migraine |
7.7% |
Disturbance In Attention |
3.8% |
Add |
1.9% |
Narcolepsy |
1.9% |
Product Used For Unknown Indication |
1.9% |
|
Product Substitution Issue |
40.0% |
Product Quality Issue |
6.7% |
Tic |
6.7% |
Myalgia |
4.4% |
Psychiatric Symptom |
4.4% |
Psychotic Disorder |
4.4% |
Somnolence |
4.4% |
Accidental Exposure To Product |
2.2% |
Fatigue |
2.2% |
Haematochezia |
2.2% |
Hallucination, Visual |
2.2% |
Headache |
2.2% |
Mania |
2.2% |
Medication Error |
2.2% |
Myocardial Infarction |
2.2% |
Nausea |
2.2% |
No Adverse Event |
2.2% |
Physical Assault |
2.2% |
Poisoning |
2.2% |
Pruritus Generalised |
2.2% |
|
Secondary |
Product Used For Unknown Indication |
27.7% |
Attention Deficit/hyperactivity Disorder |
18.5% |
Drug Dependence |
8.9% |
Depression |
7.5% |
Anxiety |
5.5% |
Drug Abuse |
5.5% |
Major Depression |
2.7% |
Pain |
2.7% |
Bipolar Disorder |
2.4% |
Foetal Exposure During Pregnancy |
2.4% |
Blood Oestrogen Increased |
2.1% |
Depressive Disorder |
2.1% |
Migraine |
2.1% |
Progesterone Decreased |
2.1% |
Sleep Disorder |
1.7% |
Substance Abuse |
1.7% |
Affective Disorder |
1.4% |
Convulsion |
1.0% |
Hypersensitivity |
1.0% |
Insomnia |
1.0% |
|
Suicidal Ideation |
11.3% |
Serotonin Syndrome |
8.1% |
Off Label Use |
6.5% |
Weight Decreased |
6.5% |
Wrong Technique In Drug Usage Process |
6.5% |
Drug Abuse |
4.8% |
Drug Hypersensitivity |
4.8% |
Somnolence |
4.8% |
Suicide Attempt |
4.8% |
Syncope |
4.8% |
Theft |
4.8% |
Unresponsive To Stimuli |
4.8% |
Weight Increased |
4.8% |
Antiphospholipid Antibodies Positive |
3.2% |
Drug Dependence |
3.2% |
Limb Injury |
3.2% |
Overdose |
3.2% |
Restlessness |
3.2% |
Sinus Tachycardia |
3.2% |
Substance Abuse |
3.2% |
|
Concomitant |
Product Used For Unknown Indication |
39.2% |
Attention Deficit/hyperactivity Disorder |
9.9% |
Depression |
7.2% |
Multiple Sclerosis |
6.5% |
Anxiety |
4.3% |
Pain |
3.7% |
Bipolar Disorder |
3.3% |
Contraception |
3.2% |
Agoraphobia |
2.4% |
Rheumatoid Arthritis |
2.4% |
Insomnia |
2.2% |
Crohn's Disease |
2.2% |
Sleep Disorder |
2.2% |
Intervertebral Disc Protrusion |
2.1% |
Hypertension |
1.7% |
Gastrooesophageal Reflux Disease |
1.7% |
Acne |
1.5% |
Asthma |
1.5% |
Psoriasis |
1.4% |
Back Pain |
1.4% |
|
Weight Increased |
11.2% |
Pain |
8.7% |
Vomiting |
8.0% |
Weight Decreased |
7.4% |
Injection Site Pain |
7.1% |
Pulmonary Embolism |
6.4% |
Nausea |
5.8% |
Suicidal Ideation |
5.1% |
Off Label Use |
4.8% |
Drug Ineffective |
4.2% |
Pain In Extremity |
3.8% |
Visual Impairment |
3.8% |
Urinary Tract Infection |
3.5% |
Menstruation Irregular |
3.2% |
Rash |
3.2% |
Tremor |
3.2% |
Convulsion |
2.9% |
Sinusitis |
2.9% |
Vision Blurred |
2.6% |
Deep Vein Thrombosis |
2.2% |
|
Interacting |
Blood Pressure Abnormal |
12.5% |
Depression |
12.5% |
Product Used For Unknown Indication |
12.5% |
Blood Glucose Increased |
6.3% |
Chronic Myeloid Leukaemia |
6.3% |
Depressed Level Of Consciousness |
6.3% |
Disturbance In Attention |
6.3% |
Ejaculation Disorder |
6.3% |
Erectile Dysfunction |
6.3% |
Hypertension |
6.3% |
Narcolepsy |
6.3% |
Smoking Cessation Therapy |
6.3% |
Substance-induced Mood Disorder |
6.3% |
|
Feeling Jittery |
12.5% |
Inhibitory Drug Interaction |
12.5% |
Lip And/or Oral Cavity Cancer |
12.5% |
Road Traffic Accident |
12.5% |
Somnolence |
12.5% |
Thinking Abnormal |
12.5% |
Thrombosis In Device |
12.5% |
Tremor |
12.5% |
|